Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

4.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

24.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

12.1K
12.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human endogenous retrovirus envelope proteins alter extracellular vesicle cellular interactions and biodistribution.

bioRxiv : the preprint server for biology·2026
Same author

Proteomic identification and validation of novel neuronal EV-based markers for Alzheimer's disease biomarker discovery.

bioRxiv : the preprint server for biology·2026
Same author

Proteomic profiling of brain organoids and extracellular vesicles identifies early Alzheimer's disease biomarkers and drug response heterogeneity.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Circulating extracellular vesicle microRNAs mediate immune modulation of social behavior in male mice.

Nature communications·2026
Same author

Extracellular vesicle analysis.

Nature reviews. Methods primers·2026
Same author

Tissue-Specific Extracellular Vesicles Enriched From Circulation: Exploring the Liquid Biopsy Perspective.

Journal of extracellular biology·2026
Same journal

Design-Expert Assisted Formulation Development, Optimization, and Evaluation of Selegiline and Biochanin A Loaded Self-Nanoemulsifying Drug Delivery System.

Drug development research·2026
Same journal

Contrastive Learning-Powered Ultrafast Genome-Wide Virtual Screening: The Rise of DrugCLIP.

Drug development research·2026
Same journal

Design, Synthesis, and Biological Evaluation of Chiral Urea and Thiourea Derivatives as Multitarget-Directed Anti-Alzheimer Agents.

Drug development research·2026
Same journal

Benzimidazole-Based VEGFR-2 Inhibitors Inspired by Sorafenib: Synthesis, Biological Evaluation, and Mechanistic Insights.

Drug development research·2026
Same journal

Luliconazole Potentiates Efficacy of Miltefosine Against Leishmania donovani.

Drug development research·2026
Same journal

Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease.

Drug development research·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

A Complete Pipeline for Isolating and Sequencing MicroRNAs, and Analyzing Them Using Open Source Tools
09:29

A Complete Pipeline for Isolating and Sequencing MicroRNAs, and Analyzing Them Using Open Source Tools

Published on: August 21, 2019

8.0K

Validated MicroRNA Target Databases: An Evaluation.

Yun Ji Diana Lee1, Veronica Kim1, Dillon C Muth1

  • 1Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD, 21205, USA.

Drug Development Research
|August 20, 2015
PubMed
Summary
This summary is machine-generated.

MicroRNA (miRNA) therapeutics show promise, but predicting off-target effects is challenging. A review of miRNA target databases revealed inaccuracies and inconsistencies, highlighting the need for careful validation of these resources.

Keywords:
databaseinteractionmicroRNAoff-target effectvalidation

More Related Videos

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
11:00

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs

Published on: June 12, 2018

14.8K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Experiment Videos

Last Updated: Apr 5, 2026

A Complete Pipeline for Isolating and Sequencing MicroRNAs, and Analyzing Them Using Open Source Tools
09:29

A Complete Pipeline for Isolating and Sequencing MicroRNAs, and Analyzing Them Using Open Source Tools

Published on: August 21, 2019

8.0K
Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
11:00

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs

Published on: June 12, 2018

14.8K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Area of Science:

  • Biochemistry and Molecular Biology
  • Bioinformatics and Computational Biology
  • Pharmacology and Therapeutics

Background:

  • MicroRNA (miRNA) research shows promise for novel therapeutics targeting gene expression.
  • Assessing potential off-target effects of miRNA-based therapies is crucial for safety and efficacy.
  • Existing databases of experimentally validated miRNA:target interactions are incomplete and their accuracy is uncertain.

Purpose of the Study:

  • To evaluate the performance and stability of four major miRNA:target interaction databases.
  • To assess the quality and experimental support for reported miRNA:target interactions.
  • To determine the reliability of these databases for predicting miRNA off-target effects.

Main Methods:

  • Systematic evaluation of four miRNA target databases: miRWalk 2.0, miRTarBase, miRecords, and TarBase 7.0.
  • Analysis of 50 alphabetically consecutive genes to identify reported miRNA targets.
  • Examination of supporting citations for experimental validation and assessment of database stability over five months.

Main Results:

  • Significant variation in performance and content was observed across the evaluated databases.
  • Two databases showed substantial changes in data over a five-month period, indicating instability.
  • Many reported interactions lacked strong experimental support, with some results likely stemming from simplistic text searches.

Conclusions:

  • While miRNA validation databases offer valuable information, their accuracy and up-to-dateness are not guaranteed.
  • The quality of evidence for reported miRNA:target interactions varies considerably, with limited cross-validation.
  • Comprehensive databases can serve as starting points for investigating off-target effects of small RNA therapies, but results require rigorous validation.